BioCentury
ARTICLE | Company News

AmideBio sales and marketing update

July 1, 2013 7:00 AM UTC

AmideBio launched its BioPure Amyloid-beta 1-42 peptide ( beta amyloid 42) in laboratory research quantities (50-1,000 µg) for use in Alzheimer's disease (AD) research. The company also markets labora...